FDA eases Tekmira Ebola drug hold; CDC chief wary
This article was originally published in Scrip
Executive Summary
Within hours after the head of a House subcommittee questioned why the FDA was keeping a clinical hold on Tekmira Pharmaceuticals' experimental Ebola drug in the midst of unprecedented outbreak of the disease in Western Africa – now declared a public health emergency of international concern by the World Health Organization – the US drug agency gave the company the go-ahead to use the investigational medicine in patients infected with the deadly virus.